Press Release: Experts to Discuss Alzheimer’s, Autism, Schizophrenia, and more


Experts to Discuss Alzheimer’s, Autism, Schizophrenia, and Cause of Migraines at Upcoming Meeting 
Leading Neuroscientists and Neurologists prepare for
American Neurological Association annual meeting, October 12-14 in Baltimore, MD

MT. LAUREL, N.J., October 3, 2014 – Attendees of the 139th annual meeting of the American Neurological Association (ANA) will hear from leading academic neurologists and neuroscientists from across the globe as the latest advances in research are presented, October 12-14 in Baltimore, MD.

Highlights of the upcoming meeting include a keynote address to be delivered by Nobel Laureate Dr. Thomas Südhof, the Avram Goldstein Professor at the Stanford University School of Medicine, and Investigator at the Howard Hughes Medical Institute. Südhof’s address will focus on synaptic physiology and the shared features of synaptic dysfunction in pathophysiology of many neurological diseases.

“This meeting will bring together leaders in academic and clinical neurology from around the country to discuss the interface between neurological science and disease,” said Sam Pleasure, M.D., Ph.D., chair of the Scientific Program Advisory Committee of the ANA.

Featured sessions include:

  • Novel Concepts in Pain Generation and Treatment, a symposium focused on basic concepts and treatment challenges associated with neuropathic pain. During this session, Dr. Peter Goadsby of the University of California, San Francisco, will discuss results from clinical trials focusing on the role of Gepants in migraines.
  • Neurological Challenges Posed by Recurring and New Viral Infections, the closing symposium of the three-day event, will focus on various ways that viral diseases of the nervous system impact neurologic care, including the identification of newly emerging viral illnesses and the long-term effects of living with HIV/AIDS.
  • Diseases of the Synapse; highlighting the latest data in synapse biology and understanding the role of synaptic dysfunction in diseases such as autism, Alzheimer’s disease, and schizophrenia.
  • Derek Denny-Brown Young Neurological Scholar Symposium, which will showcase early- to mid-career neurologists and neuroscientists who have made outstanding basic and clinical scientific advances toward the prevention, diagnosis, treatment, and cure of neurological diseases.
  • The Presidential Symposium, focusing on the expanding roles of repeat mutations in ALS and related diseases and potential treatments to address this pathophysiology.

Throughout the event, attendees will have the opportunity to participate in special interest group sub-meetings, focusing on various topics including autoimmune neurology, behavioral neurology, cerebrovascular disease, multiple sclerosis, movement disorders, dementia and aging, neuromuscular disease, plus much more. The meeting will feature several interactive workshops, scientific sessions, and more than 400 abstract presentations delivering the most timely, transformational advances in all areas of neurologic research.

About ANA

Founded in 1874, the American Neurological Association, is the premier professional society of academic neurologists and neuroscientists devoted to advancing the goals of academic neurology; to training and educating neurologists and other physicians in the neurologic sciences; and to expanding both our understanding of diseases of the nervous system of our ability to treat them. For more information, visit


Media Contact:
Caitlin Watterson